A detailed history of Lazard Asset Management LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 26 shares of PRME stock, worth $68. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 72 63.89%
Holding current value
$68
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.41 - $6.7 $156 - $308
-46 Reduced 63.89%
26 $0
Q2 2024

Aug 14, 2024

SELL
$4.3 - $8.03 $4,480 - $8,367
-1,042 Reduced 93.54%
72 $0
Q1 2024

May 14, 2024

SELL
$6.35 - $9.39 $3,924 - $5,803
-618 Reduced 35.68%
1,114 $7,000
Q4 2023

Feb 14, 2024

BUY
$5.59 - $9.55 $346 - $592
62 Added 3.71%
1,732 $15,000
Q3 2023

Nov 14, 2023

BUY
$9.5 - $15.07 $627 - $994
66 Added 4.11%
1,670 $15,000
Q2 2023

Aug 14, 2023

BUY
$11.41 - $17.05 $650 - $971
57 Added 3.68%
1,604 $23,000
Q1 2023

May 15, 2023

BUY
$11.21 - $21.11 $17,341 - $32,657
1,547 New
1,547 $18,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $253M
More about PRME
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.